Preview

Vestnik natsional'nogo issledovatel'skogo yadernogo universiteta "MIFI"

Advanced search

Mathematical Analysis of Patient Screening Results to Predict Preeclampsia

https://doi.org/10.1134/S2304487X20050041

Abstract

   The screening of pregnant women in the Moscow region has been performed jointly by mathematicians and doctors to detect prognostic signs of pre-eclampsia, which is a very serious complication of pregnancy, often resulting in the death of the mother and fetus. The mathematical analysis of preliminary experimental data is carried out. As signs (markers) of a possible complication, the angio- and anti-angiogenic proteins PlGF (placental vascular growth factor) and sFlt-1 (a factor inhibiting vascular growth), as well as their ratio, have been considered. Depending on the gestational age, sliding standards have been obtained for patients with a successful pregnancy for each of the factors. The method of logical symptoms has been used to seek prognostic rules. The symptom list contains the concentrations of the indicated proteins in the blood serum and their ratios, expressed on a percentile scale and obtained at different pregnancy periods. A mask of “the class of successful patients versus the class with the most severe form of preeclampsia” has been constructed. The indistinguishability values of logical vectors from the mask have been calculated for each patient. Two boundaries have been obtained for the indistinguishability u. It has been shown that u ≲ 0.348 indicates a risk of developing preeclampsia, and the patients require further monitoring. At u ≲ 0.18, preeclampsia will almost certainly develop.

About the Authors

V. M. Guryeva
Moscow Regional Research Institute of Obstetrics and Gynecology
Russian Federation

101000

Moscow



Yu. B. Kotov
Keldysh Institute of Applied Mathematics, Russian Academy of Sciences
Russian Federation

125047

Moscow



M. O. Matveev
Moscow Regional Research Institute of Obstetrics and Gynecology
Russian Federation

101000

Moscow



T. A. Semenova
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
Russian Federation

115409

Moscow



A. A. Travkina
Moscow Regional Research Institute of Obstetrics and Gynecology
Russian Federation

101000

Moscow



T. S. Budykina
Moscow Regional Research Institute of Obstetrics and Gynecology
Russian Federation

101000

Moscow



References

1. Say L., Chou D., Gemmill A., Tuncalp O., Moller A. B., Daniels J. et al. Global causes of maternal death: a WHO systematic analysis // Lancet Glob Health. 2014. V. 2. P. e323–33.

2. Bellamy L., Casas J. P., Hingorani A. D., Williams D. J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis // BMJ. 2007. V. 335. № 7627. P. 974. doi: 10.1136/bmj.39335.385301.BE

3. Hollegaard B., Lykke J. A., Boomsma J. J. Time from pre-eclampsia diagnosis to delivery affects future health prospects of children // Evol. Med. Public Health. 2017. V. 2017. № 1. P. 53–66. doi: 10.1093/emph/eox004

4. Jose Carlos Peracoli, Vera Therezinha Medeiros Borges, Jose Geraldo Lopes Ramos, Ricardo de Carvalho Cavalli, Sergio Hofmeister de Almeida Martins Costa, Leandro Gustavo de Oliveira, Francisco Lazaro Pereira de Souza, Henri Augusto Korkes, Ione Rodrigues Brum, Maria Laura Costa, Mario Dias Correa Junior, Nelson Sass, Angelica Lemos Debs Diniz, Caio Antonio de Campos Prado, Edson Viera da Cunha Filho. Pre-eclampsia/Eclampsia // Rev Bras Ginecol Obstet. 2019. V. 41. № 5. P. 318–332. doi: 10.1055/s-0039-1687859

5. Shalina R. I., Mikhaleva L. M., Simukhina M. A., Konopliannikov A. G., Shtabnitskiyj A. M., Osobennosti techeniya tiazhelihkh form pre-eclampsii v sovremennihkj usloviyahkh (Features of the course of severe forms of preeclampsia in modern conditions), Questions of Gynecology, Obstetrics and Perinatology, 2017, vol. 16, no. 6, pp. 16–23 (in Russian).

6. Palm M., Basu S., Larsson A. et al. A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy // ACTA Obstetricia et Gynecologica Scand. 2011. V. 90. № 11. P. 1244–1251.

7. Ivanets T. Yu., Alekseeva M. L., Loginova N. S. et al., Platsentarnyj facyor rosta i fmsodobnaya tirozinkinaza-1 kak markery preeclampsii v dinamike beremennosti (Placental growth factor and fms-like tyrosine kinase-1 as markers of preeclampsia in the dynamics of pregnancy), Clinical Laboratory Diagnostics, 2013, no. 8, pp. 14–17 (in Russian).

8. Guryeva V. M., Travkina A. A., Matveev M. O., Morokhotova L. S., Kotov Ju. B., Semenova T. A., Preeclampsia prevention options: today and tomorrow, Farmateka, 2020, no. 6, pp. 24–33. doi: 10.18565/pharmateca.2020.6.24-32 (in Russian)

9. Burton G. I., Charnock-Jones D. S., Jauniaux E. Regulation of vascular growth and function in the human placenta // Reproduction. 2009. V. 138. № 6. P. 895–902.

10. Order of the Ministry of Health of the Moscow Region No. 1072 of 23.07.2018 “On the organization of work on early screening of preeclampsia in pregnant women in the Moscow Region”.

11. Kotov Yu. B., Novye matematicheskiye podkhody k zadacham meditsinskoy diagnostiki (New mathematical approach to medical diagnostic problems), Moscow: Editorial URSS, 2004, 328 p. (in Russian).

12. Orlov A. I., Nechislovaja statistica (Non-Numeric Statistics), Moscow: MZ-Press, 2004, 513 p. (in Russian).

13. Barinova I. V., Kotov Yu. B., Nicolskaya I. G., Semenova T. A., Mnogomernyj matematicheskiyj metod klassifikatsii patsientov (Multivariate Mathematical Method of Patients Classification), Vestnik NIYaU MIFI, 2017, Vol. 6, no. 2, pp. 183–190. doi: 10.1134/S2304487X17020031 (in Russian).

14. Guryeva V. M., Kotov Yu. B., Morohotova L. S., Semenova T. A., Tekhnologiya podbora maski v methode logicheskikh simptomov (Technology of mask formation in the method of logical symptoms), Vestnik NIYaU MIFI, 2017, vol. 6, no. 4, pp. 368–376.doi: 10.1134/S2304487X17040058 (in Russian).

15. Kotov Yu. B., Semenova T. Mathematical Methods for Solving Cognitive Problems in Medical Diagnosis // BICA2020 (в пeчaти).

16. Stepan H., Herraiz I., Schlembach D., Verlohren S., Brennecke S., Chantraine F., Klein E., Lapaire O., Llurba E., Ramoni A., Vatish M., Wertaschnigg D., Galindo A. Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice // Ultrasound Obstet. Gynecol. 2015. V. 45. P. 241–246.

17. Gomez-Arriaga P.I., Herraiz I., Lopez-Jimenez E.A., Escribano D., Denk B., Galindo A. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia // Ultrasound Obstet. Gynecol. 2014. V. 43. P. 525–532.


Review

For citations:


Guryeva V.M., Kotov Yu.B., Matveev M.O., Semenova T.A., Travkina A.A., Budykina T.S. Mathematical Analysis of Patient Screening Results to Predict Preeclampsia. Vestnik natsional'nogo issledovatel'skogo yadernogo universiteta "MIFI". 2020;9(6):567-576. (In Russ.) https://doi.org/10.1134/S2304487X20050041

Views: 114


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2304-487X (Print)